Contraceptives Market Analysis | 2022-2028

“The Contraceptives Market was estimated at US$ 27.1 billion in 2021 and is expected to grow at a CAGR of 6.18% during 2022-2028 to reach US$ 50.9 billion in 2028”.

Wish to get a free sample? Register Here

Market Dynamics

Introduction

Contraceptives are a diverse range of methods and devices designed to prevent unwanted pregnancies by inhibiting conception. They function by interfering with the process of fertilization or altering the uterine environment. Highly effective contraceptives, like birth control pills, IUDs, contraceptive implants, sterilization, and contraceptive injections, offer reliable protection when used correctly.

Barrier methods, such as condoms, create a physical barrier to prevent sperm from reaching the egg. Additionally, fertility awareness methods involve tracking menstrual cycles to determine fertile days. Contraceptives offer individuals the ability to make informed choices about family planning and reproductive health, promoting control over their reproductive futures.

Market Drivers

During the forecast period, the market growth is anticipated to be driven by the rising incidence of Sexually Transmitted Diseases (STDs) and the rising number of women with unmet needs for contraceptive medications & devices. According to the World Health Organization, around 1.1 billion women worldwide in 2019 who are of reproductive age (15 to 49 years) need family planning. Around 842 million of them use contraceptive techniques for family planning, and 270 million of them have unmet contraception needs.

The increase in market growth is explained by an increase in governmental activities, a rise in population control demands, and a decline in the prevalence of unplanned pregnancies. The Center for Reproductive Rights estimates that every year in Asia, there are about 53.8 million unwanted pregnancies, with about 65% of them ending in abortions. In Asia, about 41% of married teens use contraception regularly.

During the projection period, it is projected that the introduction of programs aimed at lowering unintended pregnancies and the associated healthcare expenses as well as raising user awareness levels will fuel market growth. Additionally, the rise in unwanted pregnancies is anticipated to aid in the market's expansion throughout the projected year. The Lancet Global Health estimates that between 2015 and 2019, there were approximately 121 million unplanned pregnancies worldwide or 64 unwanted conceptions for every 1000 women of reproductive age. Governments and healthcare organizations have started several programs for family planning that support the use and production of contraceptives, including Every Woman Every Child, the Millennium Development Goals, the 2030 Sustainable Development Goals (SDGs), and Family Planning 2020 (FP2020).

The public-sector entities' higher purchase volumes are drivers for growth. The market for contraceptive pills, including combination hormonal contraceptives and progestin-only tablets, accounted for over 201 million FP2020 market volumes, according to the Family Planning 2021 report by the Clinton Health Access Initiative. Comparatively speaking, these pills are less expensive than contraceptive methods. According to an article in The Lancet, contraceptive pills accounted for about 14.8% of all contraceptive prevalence in 2019.

The rising awareness boosts market growth. According to a 2022 article in the journal Global Health: Science and Practice, about 41% of Asian women who use contraceptives get them from private sources, while about 56% get them from public sources. Around 63% of women in the 36 countries reviewed for the Low- and Middle-income Countries (LMIC) get it from private sources, while 34% get it from public sources. To increase youth awareness and encourage the use of contraceptives to prevent STDs and unintended pregnancies, governments in many different nations have been running large campaigns and sex education programs. Raising awareness regarding safe sex through condoms is a major responsibility of government and international healthcare organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).

Family Planning 2020 was a program that was started in 2012 and operated until the year 2020. It enabled international collaborations to share information and promote a person-centered, right-based approach to family planning. The effort's goal was subsequently extended to the year 2030 to guarantee that family planning tools and contraception are available everywhere. The primary sources of contraceptives worldwide are both the commercial sector (pharmacies/drug stores, general stores/markets, private clinics, and NGOs or Faith-based groups). Short-acting resupply contraceptive techniques, including condoms and contraceptive tablets, are predominantly used by the private sector, which has seized and kept a comparatively consistent proportion of the industry.

Several investments/guidelines in the industry have been directed in recent years, which would boost the overall market. Some of them are:

• In Germany, the mandatory health insurance program for girls under the age of 18 covers IUDs, emergency contraception, and hormonal contraceptives with a prescription, according to the Center for Reproductive Rights' Access to Contraceptives in the European Union Report. For women between the ages of 18 and 19, there is a 10% co-payment with a ceiling of 10 euros per prescription. Women who are 20 years of age or older and who need contraceptives for purposes other than pregnancy prevention are covered under the program.

Recent Developments

The market for contraceptives is highly competitive. The state of the economy and government assistance have a direct impact on the expansion of businesses. Based on their product's quality and market penetration in both the target and growing markets, these companies distinguish their contraceptive drivers in the industry. Furthermore, recent important mergers and acquisitions in the sector have had a big impact on the dynamics of competition. For instance:

• In July 2021, HRA Pharma was given the go-ahead by the MHRA to introduce a contraceptive pill (a Desogestrel-only pill) that will be sold over the counter in the United Kingdom.

Segments Analysis

By Product Type

The market is further segmented into drugs and devices.

By Drugs Type

“The condoms category held the largest share in 2021 due to growing demand in Europe and Asia Pacific”.

The market is further segmented into contraceptive pills, patches, and injectables. The devices segment is further segmented into condoms, subdermal implants, IUDs, vaginal rings, and others. The condoms segment is further bifurcated into male and female condoms. In addition to that, the IUD segment is further categorized into copper IUDs and hormonal IUDs. Due to the expanding demand in the regions of Europe and Asia Pacific, the condoms category had the biggest share in 2021.

The demand from the public sector is another factor that has contributed to the growth. The Department of Health & Family Welfare in India provided about 378.1 million condom units, according to the Family Planning Report 2021 report. The market for contraceptive medications is anticipated to grow profitably throughout the forecast period.

By Distribution Channel Type

The market is segmented into hospital pharmacies, retail pharmacies, and e-commerce.

Regional Analysis 

“North America led in revenue share in 2021 and is expected to maintain this position, while Asia Pacific is projected to have the fastest CAGR during the forecast period”.

The contraceptive market is broken down geographically into areas like North America, Europe, Asia-Pacific, and the Rest of the World (RoW). Due to the high rate of abortion, the growing population of women between the ages of 15 and 44, and high patient awareness levels in the area, North America held the largest revenue share in 2021 and is anticipated to keep this position throughout the forecast period.

Teenagers' desire for contraceptives has increased as a result of the introduction of generic and inexpensive medications and technologies. In April 2022, Reckitt Benckiser introduced Durex Intense, a new condom category. Asia Pacific is expected to experience the quickest CAGR during the forecast period.

Key Players

The following are the key players in the Contraceptives Market (arranged alphabetically)

• Abbvie, Inc.
• Afaxys, Inc.
• Agile Therapeutics
• Bayer AG
• China Resources Zizhu Pharmaceutical Co., Ltd. (CR Zizhu)
• Church & Dwight
• Cupid Ltd.
• Helm AG
• Janssen Pharmaceuticals, Inc.
• Organon Group of Companies
• Pfizer Inc.
• Veru, Inc.
• Viatris (Mylan)

The overall competitive landscape has been affected due to these mergers and acquisitions. 

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

What Deliverables Will You Get in this Report?

Research Methodology

This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

We conducted more than 15 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to three players)
• SWOT analysis of key players (up to three players)

Competitive Benchmarking

• Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research:

Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.